Johnson & Johnson (JNJ) Acquisitions (2009 - 2025)
Johnson & Johnson (JNJ) posted Acquisitions of $3.0 billion for Q4 2025, up 304000.0% sequentially from $1.0 million in Q3 2025, and up 304000.0% YoY from N/an in Q4 2024.
Johnson & Johnson (JNJ) Acquisitions (2009 - 2025) Analysis & Trends
Johnson & Johnson (JNJ) has 17 years of Acquisitions data on file, last reported at $3.0 billion in Q4 2025.
- Quarterly Acquisitions rose 304000.0% year-over-year to $3.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.5 billion (up 223.36% YoY) and the FY2025 annual result came in at $17.5 billion, up 15.54% from the prior year.
- Acquisitions improved to $3.0 billion in Q4 2025 per JNJ's latest filing, from $1.0 million in the prior quarter.
- The five-year high for Acquisitions was $17.7 billion in Q1 2023, with the low at $1.0 million in Q4 2024.
- Average Acquisitions over 5 years is $4.5 billion, with a median of $1.8 billion recorded in 2024.
- Year-over-year, Acquisitions sank 99.95% in 2024 and surged 304000.0% in 2025.
- Johnson & Johnson's Acquisitions stood at $6.4 billion in 2021, then slumped by 96.05% to $252.0 million in 2022, then surged by 653.97% to $1.9 billion in 2023, then slumped by 99.95% to $1.0 million in 2024, then surged by 304000.0% to $3.0 billion in 2025.
- Business Quant data shows JNJ's Acquisitions at $3.0 billion in Q4 2025, $1.0 million in Q3 2025, and $14.5 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 7.56 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 8.78 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 109.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2025 | 3.04 Bn |
| Sep 28, 2025 | 1.00 Mn |
| Jun 29, 2025 | 14.46 Bn |
| Dec 29, 2024 | 1.00 Mn |
| Sep 29, 2024 | 1.80 Bn |
| Jun 30, 2024 | 1.80 Bn |
| Mar 31, 2024 | 1.81 Bn |
| Dec 31, 2023 | 1.90 Bn |
| Jan 1, 2023 | 17.65 Bn |
| Apr 3, 2022 | 252.00 Mn |
| Jan 3, 2021 | 6.37 Bn |
| Jun 28, 2020 | 800.00 Mn |
| Mar 29, 2020 | 939.00 Mn |
| Dec 29, 2019 | 4.90 Bn |
| Sep 29, 2019 | 216.00 Mn |
| Jun 30, 2019 | 3.40 Bn |
| Mar 31, 2019 | 1.68 Bn |
| Sep 30, 2018 | 675.00 Mn |
| Jul 1, 2018 | 140.00 Mn |
| Apr 1, 2018 | 82.00 Mn |